Open access
Open access
Powered by Google Translator Translator

Daily Archives: October 12, 2021

RCT: No benefit from antithrombotic therapy (aspirin or apixaban) in outpatients with clinically stable symptomatic COVID-19.

12 Oct, 2021 | 00:28h | UTC

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial – JAMA

Editorial: Antithrombotic Therapy for Outpatients With COVID-19: Implications for Clinical Practice and Future Research – JAMA

 

Commentary on Twitter

 


Nationwide study in Sweden shows link between COVID vaccination and reduced household transmission.

12 Oct, 2021 | 00:25h | UTC

News release: Nationwide study shows link between COVID vaccination and reduced household transmission – Umea University

Original study: Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members – JAMA Internal Medicine

Related:

Review | Prevention of host-to-host transmission by SARS-CoV-2 vaccines.

Study ties COVID vaccines to lower transmission rates.

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England – “the likelihood of household transmission was approximately 40 to 50% lower in households of index patients who had been vaccinated 21 days or more before testing positive than in households of unvaccinated index patients”.

Study in England showed one dose of COVID-19 vaccine can cut household transmission by up to half – This protection is on top of the reduced risk of a vaccinated person developing symptomatic infection, which is around 60 to 65% after the first dose

Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.

 


D-Dimer testing for the exclusion of pulmonary embolism has limited clinical utility among hospitalized patients with COVID-19 – most patients with or without pulmonary embolism have increased levels.

12 Oct, 2021 | 00:26h | UTC

D-Dimer Testing for the Exclusion of Pulmonary Embolism Among Hospitalized Patients With COVID-19 – JAMA Network Open

Commentary: D-Dimer Level Not Useful for Ruling Out PE in COVID-19 Patients – HealthDay

 


Covid-19: Is New Zealand’s switch in policy a step forward or a retreat?

12 Oct, 2021 | 00:21h | UTC

Covid-19: Is New Zealand’s switch in policy a step forward or a retreat? – The BMJ

Related:

New Zealand acknowledges it can no longer completely get rid of the coronavirus.

Why we must not allow COVID to become endemic in New Zealand – The Conversation

 

Commentary on Twitter

 


How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

12 Oct, 2021 | 00:18h | UTC

How antiviral pill molnupiravir shot ahead in the COVID drug hunt – Nature

Related:

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

 


WHO’s Special Report on Climate Change and Health.

12 Oct, 2021 | 00:12h | UTC

News release: WHO’s 10 calls for climate action to assure sustained recovery from COVID-19 – World Health Organization

Report: COP26 Special Report on Climate Change and Health – World Health Organization

Commentary: ‘Burning of Fossil Fuels is Killing Us’ – Declares New WHO Climate and Health Report – Health Policy Watch

 

Commentary on Twitter (thread – click for more)

 


Why easing COVID restrictions could prompt a fierce flu rebound – “As pandemic restrictions ease, other respiratory viruses are returning in unexpected ways”.

12 Oct, 2021 | 00:19h | UTC

Why easing COVID restrictions could prompt a fierce flu rebound – Nature

 


The BMJ Series on Climate Emergency and Health Professionals – Call for emergency action to limit global temperature increases, restore biodiversity, and protect health.

12 Oct, 2021 | 00:10h | UTC

Homepage

Accelerating climate action: the role of health professionals

Changing behaviour for net zero 2050

From drug discovery to coronaviruses: why restoring natural habitats is good for human health

Covid-19, climate change, and the environment: a sustainable, inclusive, and resilient global recovery

Health risks of extreme heat

How to achieve a net zero carbon NHS during a pandemic

A world on the edge of climate disaster

David Oliver: Outpatient clinics’ role in sustainability

Helen Salisbury: The time is now

Rammya Mathew: Climate action will require radical reform of how we practise medicine

Overdiagnosis is increasing the carbon footprint of healthcare

The climate crisis and the rise of eco-anxiety

How can I be an environmentally conscious healthcare practitioner?

Talking to patients about the climate emergency

COP26: a missed opportunity for climate leadership

Making outpatient care sustainable for the future

A planetary health curriculum for medicine

Why I . . . am a green GP

 


AHA Scientific Statement: Medication Adherence and Blood Pressure Control.

12 Oct, 2021 | 00:09h | UTC

Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association – Hypertension

News release: Health system crucial to improve medication adherence for people managing hypertension – American Heart Association

Top Things to Know: Medication Adherence and Blood Pressure Control – American Heart Association

Commentary: Medication Adherence – Is It Really the Patient’s Fault? – American Heart Association

 


RCT: In stable patients who have undergone PCI for acute myocardial infarction, de-escalation from aspirin + ticagrelor to aspirin + clopidogrel after 1 month reduced bleeding events without increasing cardiovascular risk.

12 Oct, 2021 | 00:06h | UTC

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial – The Lancet (link to abstract – $ for full-text)

Commentary: Adopting a clopidogrel-based DAPT strategy after PCI boosts outcomes for heart attack patients – Cardiovascular Business

 


RCT: Spinal Anesthesia not Superior to General Anesthesia for Hip Surgery in Older Adults.

12 Oct, 2021 | 00:07h | UTC

Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults – New England Journal of Medicine (link to abstract – $ for full-text)

News release: Myth busted: General anesthesia just as safe as spinal anesthesia after broken hip surgery – Penn Medicine

Commentary: Study Finds Spinal Anesthesia Not Superior to General Anesthesia for Hip-Fracture Surgery – BreakingMed

Related: RCT: Similar long-term survival after combined epidural–general anesthesia vs. general anesthesia alone.

 


RCT: In patients with acute ischemic stroke and large vessel occlusion, thrombectomy with combined contact aspiration and stent retriever was not better than stent retriever alone.

12 Oct, 2021 | 00:04h | UTC

Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER2 Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentaries:

Little Benefit From Adding Aspiration to Thrombectomy for Stroke – Medscape (free registration required)

Combo Thrombectomy Approach No Better for Large Vessel Strokes – MedPage Today (free registration required)

 

Commentary on Twitter

 


RCT: Among patients with metastatic colorectal cancer, those randomized to systemic treatment alone had lower sixty-day mortality compared to those randomized to primary tumor resection followed by systemic treatment.

12 Oct, 2021 | 00:01h | UTC

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial – JAMA Surgery (free for a limited period)

Editorial: Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials – JAMA Surgery (free for a limited period)

Commentary: Systemic Therapy Alone Bests Surgical Tx for Metastatic CRC – BreakingMed

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.